Open access · CC-BY
via OpenAlex
Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI)
Jie Liu, Heleen van Beusekom, Xian‐Le Bu, Gong Chen, Paulo Henrique Rosado-de-Castro, Xiaochun Chen, Xiaowei Chen, Andrew N. Clarkson, Tracy D. Farr, YuHong Fu, Jianping Jia, Jukka Jolkkonen, Woojin S. Kim, Paula Korhonen, Shen Li
Neuroprotection/Neuroprotection (Chichester, England. Print) · 2023 · ▲ 28 citations
Abstract
The global trend toward aging populations has resulted in an increase in the occurrence of Alzheimer's disease (AD) and associated socioeconomic burdens. Abnormal metabolism of amyloid-β (Aβ) has been proposed as a significant pathomechanism in AD, supported by results of recent clinical trials using anti-Aβ antibodies. Nonetheless, the cognitive benefits of the current treatments are limited. The etiology of AD is multifactorial, encompassing Aβ and tau accumulation, neuroinflammation, demyelination, vascular dysfunction, and comorbidities, which collectively lead to widespread neurodegeneration in the brain and cognitive impairment. Hence, solely removing Aβ from the brain may be insufficient to combat neurodegeneration and preserve cognition. To attain effective treatment for AD, it is necessary to (1) conduct extensive research on various mechanisms that cause neurodegeneration, including advances in neuroimaging techniques for earlier detection and a more precise characterization of molecular events at scales ranging from cellular to the full system level; (2) identify neuroprotective intervention targets against different neurodegeneration mechanisms; and (3) discover novel and optimal combinations of neuroprotective intervention strategies to maintain cognitive function in AD patients. The Alzheimer's Disease Neuroprotection Research Initiative's objective is to facilitate coordinated, multidisciplinary efforts to develop systemic neuroprotective strategies to combat AD. The aim is to achieve mitigation of the full spectrum of pathological processes underlying AD, with the goal of halting or even reversing cognitive decline.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/nep3.23
- Canonical
- link ↗
- Fetched
- 2026-08-31 MST
Cite this
APA
Liu, J., Beusekom, H.V., Bu, X., Chen, G., Rosado-de-Castro, P.H., Chen, X., Chen, X., Clarkson, A.N., Farr, T.D., Fu, Y., Jia, J., Jolkkonen, J., Kim, W.S., Korhonen, P., Li, S., Liang, Y., Liu, G., Liu, G., Liu, Y., & Malm, T. (2023). Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI). <em>Neuroprotection/Neuroprotection (Chichester, England. Print)</em>. https://doi.org/10.1002/nep3.23
Vancouver
Liu J, Beusekom HV, Bu X, Chen G, Rosado-de-Castro PH, Chen X, et al. Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI). Neuroprotection/Neuroprotection (Chichester, England. Print). 2023. doi:10.1002/nep3.23.
BibTeX
@article{jie2023Preser,
title = {Preserving cognitive function in patients with Alzheimer's disease: The Alzheimer's disease neuroprotection research initiative (ADNRI)},
author = {Jie Liu and Heleen van Beusekom and Xian‐Le Bu and Gong Chen and Paulo Henrique Rosado-de-Castro and Xiaochun Chen and Xiaowei Chen and Andrew N. Clarkson and Tracy D. Farr and YuHong Fu and Jianping Jia and Jukka Jolkkonen and Woojin S. Kim and Paula Korhonen and Shen Li and Yajie Liang and Guanghui Liu and Guiyou Liu and Yuhui Liu and Tarja Malm and Xiaobo Mao and Joaquím M. Oliveira and Michel Modo and Pedro Ramos‐Cabrer and Karsten Ruscher},
journal = {Neuroprotection/Neuroprotection (Chichester, England. Print)},
year = {2023},
doi = {10.1002/nep3.23},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
The Journals of Gerontology Series A 2015
Open access · OA
Recent Developments in Understanding Brain Aging: Implications for Alzheimer’s Disease and Vascular Cognitive Impairment
International Journal of Molecular Sciences 2021
Open access · CC-BY
The Interaction of Diet and Mitochondrial Dysfunction in Aging and Cognition
Current Opinion in Neurology 2013
Citation only
Impact of brain aging and neurodegeneration on cognition
2022
Open access · CC-BY
Decision letter: Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer’s disease and neurodegeneration stratified by sex
eLife 2023
Open access · CC-BY
Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer’s disease and neurodegeneration stratified by sex
Dementia & Neuropsychologia 2016
Open access · CC-BY